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o more surgical mitral commissurotomy, closed
r open, for mitral stenosis
o the Editor,
I read with interest another comparative study
etween percutaneous balloon mitral valvuloplasty
nd closed surgical mitral commissurotomy for
itral stenosis [1]. It represents the longest period
f follow-up reported to date in these patients. In
his study, the double balloon technique was used.
Using the single Inoue balloon technique, Chen
t al., who reported good results in the world’s
argest series of 4832 patients in China in 1995
2], also reported excellent long-term (up to 11
ears) results in 202 patients in 1998 [3]. The long-
erm results in a much larger Chinese population
eported in 2000 were equally impressive [4]. Thus,
ercutaneous balloon mitral valvuloplasty by the
noue balloon technique was declared the proce-
ure of choice for treatment of mitral stenosis in
998 [5]. In fact, nomore closedmitral commissuro-
omy was performed in Fu Wai hospital, the largest
eart hospital in China, after 1996 [6] (Fig. 1).
ig. 1 Closed mitral commissurotomy procedures per-
ormed at Fu Wai Hospital and Cardiovascular Institute
nd Chinese Academy of Medical Sciences, Beijing, China.
ata kindly furnished by Dr. S.S. Hu, President of Fu Wai
ospital.
914-5087/$ — see front matter © 2009 Japanese College of CardioloThe same could be said with regard to open sur-
ical mitral commissurotomy, which too has been
argely replaced by percutaneous balloon mitral
alvuloplasty [7]. Therefore, from now on, there
hould be no more surgical mitral commissurotomy,
losed or open, for mitral stenosis.
Percutaneous balloon mitral valvuloplasty not
nly avoids all the morbidities and mortality asso-
iated with a surgical operation, open or closed,
ut also is cost effective. In the modern era of
scalating healthcare costs, physicians will do both
atients and governments a great favor by not
eferring patients with mitral stenosis for a surgical
peration [5,7].
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We would like to thank Professor Tsung O. Cheng
for his interest in our article. We do agree with
Professor Cheng that percutaneous mitral valvo-
tomy has emerged, during the past 15 years, as the
procedure of choice in most patients with symp-
tomatic mitral stenosis [1]. We do agree also about
the excellent long-term outcome of the proce-
dure, reported by many series [2—4]. However, at
the time we started the study, the procedure of
closed surgical commissurotomy was the popular
one for treatment of rheumatic mitral stenosis in
our center, being performed at a fairly low cost,
in addition to a high level of expertise of the
surgeons. Hence, it presented ﬁerce competition
to the percutaneous treatment that was at the
onset of the learning curve at that time. With the
passage of time and progressively growing experi-
ence of interventional cardiologists, percutaneous
mitral valvotomy started, increasingly, to take the
upper hand, being less invasive and associated
with lower morbidity and mortality, in comparison
with surgery [5]. Yet, in the era of evidence-
based medicine we were actually in need of a
prospective randomized controlled trial comparing
the long-term results of the percutaneous pro-
cedure versus surgery. One study presented the
long-term results of up to 7 years’ follow-up [6].
Our study, eventually, reported the longest period
of follow-up of a prospective randomized controlled
trial, with up to 15 years’ follow-up [7]. Never-
theless, not all stenotic mitral valves are eligible
for the percutaneous procedure. Recent reports
have emphasized the importance of commissural
morphology (chieﬂy commissural calciﬁcation) and
subvalvular involvement in determining immediate
outcome of percutaneous mitral valvotomy [8—10].
In patients with appreciable commissural calci-
ﬁcation and/or signiﬁcant subvalvular deformity,
the surgical option would offer a better outcome,
implying that the role of surgical mitral commis-
surotomy is still there.
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